Introduction
What is Blood Cancer?
Blood cancer is an umbrella term for cancers that develop in the body's blood-forming system — the bone marrow (where red cells, white cells and platelets are made), the lymphatic system (a network of lymph nodes, spleen and other immune tissues), and the blood itself. When one type of blood-forming cell undergoes a genetic change and begins to multiply uncontrollably, it can crowd out normal cells, disrupt immunity, and affect almost every organ of the body. This is why blood cancer symptoms vary widely depending on which type is involved.
Blood cancer treatment has been transformed over the past three decades. Childhood leukaemia, once almost uniformly fatal, is now cured in more than 85% of children. Chronic myeloid leukaemia, once a death sentence within a few years, is now controlled by a single daily tablet. Multiple myeloma, while still rarely cured, is now managed as a long-term controllable condition with modern combination therapy. Outcomes in dedicated Indian centres now approach international benchmarks for many subtypes, and Aarogyasri coverage makes intensive treatment accessible to eligible families.
Regional context
Blood Cancer in Telangana & Andhra Pradesh
Blood cancers — leukaemia, lymphoma and multiple myeloma — together make up a significant share of all cancer diagnoses across Telangana and Andhra Pradesh. Hyderabad has well-established haematology, medical oncology and bone marrow transplant services, and Aarogyasri coverage makes intensive treatment accessible to many eligible families.
Two common patterns of delayed diagnosis matter here. The first is the assumption that vague tiredness, recurrent infections, or easy bruising are nothing serious — often leading to weeks or months of self-treatment before a complete blood count is finally done. The second is the assumption that a swollen lymph node must be tuberculosis or a routine infection, leading to empirical antibiotic or anti-TB treatment before a lymph node biopsy is considered. In both situations, the single most useful step is straightforward — a complete blood count for unexplained tiredness, and a lymph node biopsy for any lymph node that has not settled in 3–4 weeks.
Specialist care
Specialist Blood Cancer Care at CION Cancer Clinics
Our NABH-accredited centres deliver evidence-based blood cancer care — from complete blood counts, bone marrow aspiration and biopsy, flow cytometry, molecular and cytogenetic testing through to risk-stratified chemotherapy, modern targeted therapy (tyrosine kinase inhibitors, BTK inhibitors, BCL-2 inhibitors, proteasome inhibitors), immunotherapy, autologous and allogeneic stem cell transplant, and CAR-T cell therapy for eligible patients — guided by NCCN and ESMO haematology protocols and reviewed for every patient by a multidisciplinary haematology-oncology tumour board. Aarogyasri coverage, EMI options and structured patient support help families through what is often a long course of treatment.
For a detailed walk-through of blood cancer diagnosis, treatment options, costs, and our specialist team, see our dedicated page on blood cancer treatment in Hyderabad.